Iridex Corp financial data

Symbol
IRIX on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
1212 Terra Bella Ave, Mountain View, CA
State of incorporation
DE
Fiscal year end
December 28
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 156 % -37.1%
Quick Ratio 67.9 % -22%
Debt-to-equity 706 % +273%
Return On Equity -231 % -207%
Return On Assets -28.6 % -10%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.8M shares +3.3%
Common Stock, Shares, Outstanding 16.6M shares +2.36%
Entity Public Float 28.3M USD -0.17%
Common Stock, Value, Issued 174K USD +1.16%
Weighted Average Number of Shares Outstanding, Basic 16.4M shares +1.93%
Weighted Average Number of Shares Outstanding, Diluted 16.4M shares +1.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 48.7M USD -6.17%
Cost of Revenue 29.2M USD -2.98%
Research and Development Expense 5.45M USD -20.2%
Selling and Marketing Expense 12.6M USD -22.5%
General and Administrative Expense 9.78M USD +11.8%
Operating Income (Loss) -8.3M USD +17%
Nonoperating Income (Expense) -540K USD -202%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.84M USD +6.73%
Income Tax Expense (Benefit) 68K USD -24.4%
Net Income (Loss) Attributable to Parent -8.91M USD +6.9%
Earnings Per Share, Basic -0.54 USD/shares +8.48%
Earnings Per Share, Diluted -0.54 USD/shares +8.48%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.39M USD -66.1%
Accounts Receivable, after Allowance for Credit Loss, Current 5.95M USD -11.5%
Inventory, Net 10.8M USD +9.2%
Assets, Current 23.6M USD -14.2%
Property, Plant and Equipment, Net 115K USD -67.2%
Operating Lease, Right-of-Use Asset 1.79M USD -31.9%
Goodwill 965K USD 0%
Other Assets, Noncurrent 1.39M USD -0.14%
Assets 29.1M USD -15.4%
Accounts Payable, Current 6.99M USD +55.3%
Employee-related Liabilities, Current 1.67M USD +3.27%
Accrued Liabilities, Current 477K USD -76.1%
Contract with Customer, Liability, Current 2.18M USD -9.48%
Liabilities, Current 16.6M USD +27.6%
Contract with Customer, Liability, Noncurrent 8.35M USD -16.7%
Operating Lease, Liability, Noncurrent 811K USD -53.7%
Other Liabilities, Noncurrent 314K USD +91.5%
Liabilities 27M USD +8.53%
Accumulated Other Comprehensive Income (Loss), Net of Tax 51K USD
Retained Earnings (Accumulated Deficit) -88M USD -11.3%
Stockholders' Equity Attributable to Parent 2.1M USD -78%
Liabilities and Equity 29.1M USD -15.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.65M USD +42%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -3K USD +93%
Common Stock, Shares Authorized 30M shares 0%
Common Stock, Shares, Issued 16.6M shares +2.36%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.62M USD +43.8%
Deferred Tax Assets, Valuation Allowance 27.1M USD +6.93%
Deferred Tax Assets, Gross 27.2M USD +6.96%
Operating Lease, Liability 1.91M USD -30.6%
Payments to Acquire Property, Plant, and Equipment 3K USD -93%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.81M USD +8.24%
Lessee, Operating Lease, Liability, to be Paid 2.03M USD -31.3%
Operating Lease, Liability, Current 1.09M USD +9.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 781K USD -29.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.2M USD +11%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20K USD -97.4%
Deferred Tax Assets, Operating Loss Carryforwards 15.1M USD +13.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.43M USD -0.28%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20K USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 84K USD +1.21%
Share-based Payment Arrangement, Expense 1.24M USD -24.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%